SARS-CoV-2 Infection
Conditions
Interventions
IMMUTOP
IMMUNITUM
SECURE
BIOCIRE
Hydroxychloroquine and Azithromycine
Sponsors
University of Lome
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Patients over 18 years of age. - Infected with a Covid-19 infection confirmed by a specific PCR. - Hospitalized. - Fever or cough - No signs of respiratory distress - Naïve of specific treatment for Covid-19. - Informed consent signed by the patient.
Exclusion criteria
Exclusion criteria: - Renal insufficiency (eGFR 3 times normal - Cirrhosis (stage = Child-Pugh B). - Pregnancy or breastfeeding. - Dementia or any other condition that does not allow for informed consent. - Any reason that, at the discretion of the investigator, would compromise patient safety and cooperation in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients with undetectable viral load | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients with clinical improvement on the 7-point ordinal scale ;Proportion of patients who died or were affected by respiratory distress syndrome;Prevalence of grade 3 and 4 adverse events in each treatment group ;Proportion of patient cured | — |
Countries
Togo
Contacts
Public ContactKOKOU Kouami
Director of the Master Research Program University lecturer of ecology and forest natural resources management
Outcome results
None listed